ASCO 2026

Oncology drug development is under intensifying pressure from complex modalities and fierce competition for sites and patients. ICON helps sponsors respond with strategic insight, scientific leadership and integrated solutions across the full development lifecycle.

Backed by 11,000+ oncology and haematology specialists, ICON has delivered 840+ oncology studies in the past five years, contributing to 60 FDA and EMA‑approved therapies, with faster start‑up and more predictable delivery through connected, research‑ready sites and purpose‑built technology.

Meet our experts at ASCO, Booth #35093 to learn about ICON’s full suite of services to support your Oncology clinical development programme.

• Oncology Drug Development Consultancy Services
• Early Phase Oncology
• Feasibility, Site & Patient Recruitment, Site Networks
• Centre for Cell & Gene Therapy
• Centre for Pediatric Clinical Development
• Decentralised Clinical Trials, including In-Home Services
• Central, Bioanalytical and Specialty Laboratories
• Cardiac Safety Solutions
• Medical Imaging
• Global Regulatory Consulting
• Real World Data Intelligence and Commercialisation & Outcomes